Literature DB >> 15985559

Long term follow up of patients treated for Helicobacter pylori infection.

R Mera1, E T H Fontham, L E Bravo, J C Bravo, M B Piazuelo, M C Camargo, P Correa.   

Abstract

BACKGROUND: Helicobacter pylori infection induces progressive inflammatory changes in the gastric mucosa that may lead to gastric cancer. Understanding long term effects resulting from the cure of this infection is needed to design cancer prevention strategies.
METHODS: A cohort of 795 adults with preneoplastic gastric lesions was randomised to receive anti-H pylori treatment and/or antioxidants. At the end of six years of intervention, those who did not receive anti-H pylori treatment were offered it. Gastric biopsies were obtained at baseline, and at 3, 6, and 12 years. A histopathology score was utilised to document changes in gastric lesions. Non-linear mixed models were used to estimate the cumulative effect of H pylori clearance on histopathology scores adjusted for follow up time, interventions, and confounders.
RESULTS: Ninety seven per cent of subjects were H pylori positive at baseline, and 53% were positive at 12 years. Subjects accumulated 1703 person years free of infection. A multivariate model showed a significant regression in histopathology score as a function of the square of H pylori negative time. Subjects who were H pylori negative had 14.8% more regression and 13.7% less progression than patients who were positive at 12 years (p = 0.001). The rate of healing of gastric lesions occurred more rapidly as years free of infection accumulated, and was more pronounced in less advanced lesions.
CONCLUSIONS: Preneoplastic gastric lesions regress at a rate equal to the square of time in patients rendered free of H pylori infection. Our findings suggest that patients with preneoplastic gastric lesions should be treated and cured of their H pylori infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985559      PMCID: PMC1462952          DOI: 10.1136/gut.2005.072009

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Helicobacter pylori genotypes may determine gastric histopathology.

Authors:  C Nogueira; C Figueiredo; F Carneiro; A T Gomes; R Barreira; P Figueira; C Salgado; L Belo; A Peixoto; J C Bravo; L E Bravo; J L Realpe; A P Plaisier; W G Quint; B Ruiz; P Correa; L J van Doorn
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.

Authors:  T Ohkusa; K Fujiki; I Takashimizu; J Kumagai; T Tanizawa; Y Eishi; T Yokoyama; M Watanabe
Journal:  Ann Intern Med       Date:  2001-03-06       Impact factor: 25.391

3.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

4.  A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.

Authors:  Liya Zhou; Joseph J Y Sung; Sanren Lin; Zhu Jin; Shigang Ding; Xuebiao Huang; Zhiwei Xia; Huilan Guo; Jianjun Liu; William Chao
Journal:  Chin Med J (Engl)       Date:  2003-01       Impact factor: 2.628

5.  Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.

Authors:  J J Sung; S R Lin; J Y Ching; L Y Zhou; K F To; R T Wang; W K Leung; E K Ng; J Y Lau; Y T Lee; C K Yeung; W Chao; S C Chung
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

Review 6.  Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.

Authors:  M Rugge; P Correa; M F Dixon; R Fiocca; T Hattori; J Lechago; G Leandro; A B Price; P Sipponen; E Solcia; H Watanabe; R M Genta
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

7.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.

Authors:  Hiroshi Ohata; Shintaro Kitauchi; Noriko Yoshimura; Kouichi Mugitani; Masataka Iwane; Hideya Nakamura; Akiyoshi Yoshikawa; Kimihiko Yanaoka; Kenji Arii; Hideyuki Tamai; Yasuhito Shimizu; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

8.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

9.  Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

Authors:  M Ito; K Haruma; T Kamada; M Mihara; S Kim; Y Kitadai; M Sumii; S Tanaka; M Yoshihara; K Chayama
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

Review 10.  Alteration of histological gastritis after cure of Helicobacter pylori infection.

Authors:  M Hojo; H Miwa; T Ohkusa; R Ohkura; A Kurosawa; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2002-11       Impact factor: 8.171

View more
  121 in total

1.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population.

Authors:  Tram Kim Lam; Neal D Freedman; Jin-Hu Fan; You-Lin Qiao; Sanford M Dawsey; Philip R Taylor; Christian C Abnet
Journal:  Am J Clin Nutr       Date:  2013-09-11       Impact factor: 7.045

3.  Unique features and risk factors of Helicobacter pylori infection at the main children's intermediate school in Rabigh, Saudi Arabia.

Authors:  Hamed Said Habib; Moustafa Abdelaal Hegazi; Hussam Aly Murad; Elamir Mahmoud Amir; Taher Fawzy Halawa; Basem Salama El-Deek
Journal:  Indian J Gastroenterol       Date:  2014-04-29

4.  Vitamin C supplementation does not protect L-gulono-gamma-lactone oxidase-deficient mice from Helicobacter pylori-induced gastritis and gastric premalignancy.

Authors:  Chung-Wei Lee; Xiang-Dong Wang; Kuo-Liong Chien; Zhongming Ge; Barry H Rickman; Arlin B Rogers; Andrea Varro; Mark T Whary; Timothy C Wang; James G Fox
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

Review 5.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 6.  New advances in targeted gastric cancer treatment.

Authors:  Daniela Cornelia Lazăr; Sorina Tăban; Marioara Cornianu; Alexandra Faur; Adrian Goldiş
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

7.  Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans.

Authors:  Jennifer M Noto; Jennifer A Gaddy; Josephine Y Lee; M Blanca Piazuelo; David B Friedman; Daniel C Colvin; Judith Romero-Gallo; Giovanni Suarez; John Loh; James C Slaughter; Shumin Tan; Douglas R Morgan; Keith T Wilson; Luis E Bravo; Pelayo Correa; Timothy L Cover; Manuel R Amieva; Richard M Peek
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 8.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  The role of microRNAs in gastrointestinal cancers.

Authors:  Yoshimasa Saito; Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

10.  Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression.

Authors:  Jennifer M Noto; Kristie L Rose; Amanda J Hachey; Alberto G Delgado; Judith Romero-Gallo; Lydia E Wroblewski; Barbara G Schneider; Shailja C Shah; Timothy L Cover; Keith T Wilson; Dawn A Israel; Juan Carlos Roa; Kevin L Schey; Yana Zavros; M Blanca Piazuelo; Richard M Peek
Journal:  Mol Cell Proteomics       Date:  2018-11-19       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.